LEPR and type 2 diabetes mellitus: In addition, it was found that empagliflozin can ameliorate cardiovascular injury, vascular dysfunction, and cognitive decline in the context of a mouse model of type 2 diabetes with spontaneous mutation of the leptin receptor [54, 55].